Innovations Hub
Seeding innovations for pressing health needs

Innovation drives everything we do to develop effective solutions for our partners as well as solve some of the hardest diagnostic challenges in global health.

Partnering with Global Access Diagnostics gives you access to our world-leading scientific team and Innovations Hub, designed to advance lateral flow technology to tackle urgent global health needs. From finding the very best reagent pairs to the engineering of superior assay choreography, we continue to pioneer work on the future of lateral flow tests, supporting a vision of connected diagnostics that are accessible to those who need them most.

CASE STUDIES & NEWS ARTICLES

People Looking At Negative Rapid Lateral Flow Test
By GADx Team

REASSURED: A framework for developing diagnostics for resource limited settings 

For global health, the need for effective diagnostics in resource-limited settings has never been more pressing. At the recent Point-of-Care Testing (POCT) Meeting in Leipzig, 130 industry leaders and…
By Dr Kevin Land

GHLabs x GADx: PoC innovation in molecular diagnostics

The sensitivity of molecular testing is now being revolutionised for point-of-care (PoC) usage. PCR, known for its high sensitivity and specificity, is the gold standard in diagnosing many infectious…
By GADx Team

Detecting multiple diseases at once: EU-funded DIDIDA project develops a cost-effective mobile based solution in Africa

The Digital Innovations and Diagnostics for Infectious Diseases in Africa (DIDIDA) had its official kick-off at the Strathmore University. DIDIDA is an ambitious project to develop reliable, low-cost, mobile…

GET IN TOUCH

For sales inquiries please contact sales@globalaccessdx.com
For technical support please contact technicalsupport@globalaccessdx.com

Frequent testing is invaluable and so it is vital to find ways to drive down the cost of kits and increase production levels. As a social enterprise, GADx can transform this process because it ‘breaks the link’ of ‘having to make profit for shareholders’.

Paul Davis
Co-founder of Mologic and pioneer of lateral flow diagnostics.